Chickenpox Vaccine Market

Chickenpox vaccine, also known as varicella vaccine, is a vaccine that protects against chickenpox.One dose of this vaccine prevents 100% of severe disease and 95% of moderate disease. Varicella vaccine is made up of Oka strain of live attenuated virus. This vaccine is safe and constitutes rare severe side effects. Moreover, varicella vaccine is 7090% effective in preventing varicella. We mainly focus on live attenuated varicella vaccine in Chickenpox Vaccine Market .

Chickenpox Vaccine Market contains market size and forecasts of Chickenpox Vaccine in global, including the following market information:

• Global Chickenpox Vaccine Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global Chickenpox Vaccine Market Sales, 2017-2022, 2023-2028, (K Doses)
• Global top five Chickenpox Vaccine companies in 2021 (%)

The global Chickenpox Vaccine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Monovalent Vaccine Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Chickenpox Vaccine include Merck, GSK, Shanghai Institute, BCHT, Changsheng, Keygen, Green Cross and Biken, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Chickenpox Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Chickenpox Vaccine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Doses)

Global Chickenpox Vaccine Market Segment Percentages, by Type, 2021 (%)

• Monovalent Vaccine
• Combination Vaccine

Global Chickenpox Vaccine Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Doses)

Global Chickenpox Vaccine Market Segment Percentages, by Application, 2021 (%)

• Kids Injection
• Adults Injection

Global Chickenpox Vaccine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Doses)

Global Chickenpox Vaccine Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Chickenpox Vaccine revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Chickenpox Vaccine revenues share in global market, 2021 (%)
• Key companies Chickenpox Vaccine sales in global market, 2017-2022 (Estimated), (K Doses)
• Key companies Chickenpox Vaccine sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Merck
• GSK
• Shanghai Institute
• BCHT
• Changsheng
• Keygen
• Green Cross
• Biken